The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...

FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

Global commercial executive with expertise across product lifecycle and therapeutic areas leading transformative brands, ...

The data appeared to slam the door on the idea that the advent of GLP-1 drugs would eliminate demand for drugs specifically ...

Bernstein analysts maintained their positive stance on Eli Lilly (NYSE:LLY) shares, reiterating an Outperform rating and a price target of $1,100.00. The endorsement comes amidst a competitive ...

Metsera has set its sights on a hefty $289 million IPO as the next-gen obesity biotech seeks to fund a phase 3 trial of its ...

Akero Therapeutics has hit a home run, reporting statistically significant results in two key 96-week metabolic ...

The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli ... sold by Lilly as Mounjaro for diabetes and Zepbound ...

A Chinese start-up’s new artificial intelligence program took the top spot in Apple’s app store, threatening U.S. dominance ...

Israel’s Cease-Fires in Lebanon and Gaza Appear Fragile Israeli forces killed at least 22 people and injured dozens more in southern Lebanon on Sunday, Lebanese officials said. In Gaza, Israel ...

HENDERSON, Ky. (WEHT) — Two Evansville parents are in custody after police say their child admitted herself to the hospital ...